The Interventional Cardiology and Cardiothoracic Research department is based at Castle Hill Hospital. Our research projects include commercial, non-commercial and in-house clinical trials which cover a wide variety of heart conditions such as Coronary Heart Disease (including angina and heart attack); and arrhythmias such as Atrial Fibrillation (AF). We conduct a number of clinical trials involving a range of treatments for these conditions such as PCI (PPCI), coronary artery bypass graft, valve surgery, ablation, and treatment with various medications. We aim to focus on studies that will benefit our patient groups and improve the care and/or treatment we are currently providing.
Our current research interests include
- Drug studies looking at new anti-coagulation treatments for atrial fibrillation ablation.
- New treatments for managing high cholesterol in patients with heart disease and acute coronary syndrome, including genetics.
- New practices/procedures to manage patients who have atrial fibrillation requiring ablation.
- New practices to manage patients who have had a heart attack requiring PPCI/PCI.
- Studies comparing strategies for managing patients with exertional angina.
- A number of observational studies looking at atrial fibrillation management, including ablation.
- Improving patient outcomes in patients with CAD or Arrhythmias.
- Clinical trials comparing new and current treatments to control intra-operative bleeding during cardiac surgery.
For further information on our research or how to get involved please contact:
Lisa Chaytor (Lead Research Nurse, Interventional Cardiology Research)
Interventional Cardiology Research
Ward 6-7 Corridor
Castle Hill Hospital
Tel. 01482 626767 / 01482 626764